GOSS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

GOSSGossamer Bio, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

GOSSGossamer Bio, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GOSS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 14 '26±71.9%▼−9.45%×0.13

Q2 FY26±51.0%▼−43.32%×0.85

Q1 FY26±22.4%▼−7.99%×0.36

Q3 FY25±26.7%▼−2.53%×0.09

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedGOSS realized, solidLLY realized, hatchedOne scale, both sides: full bar = 72%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

GOSSGossamer Bio, Inc.

9.80▲+4.08%· post 9.78

Mkt cap$59.7MRevenue$9MQ2 FY26Revenue$48MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

GOSSGossamer Bio, Inc.

LLYELI Lilly & Co

9.80▲+4.08%post 9.78

Price

1,360.90▼−0.28%post 1,358.90

$59.7M

Mkt cap

$1.2T

Q2 FY26$9M

Revenue

$24.4BQ3 FY26

FY25$48M

Revenue

$65.2BFY25

GOSS9.80▲+4.08%vsLLY1,360.90▼−0.28%ClosedNov 6 '26